Pharmaceutical manufacturers, Wyeth, are to phase out manufacturing
at its US facility as part of its consolidation plans, which will
see the gradual phasing out of all operations at the New York
facility by late 2008.
Contract biopharmaceutical manufacturer SynCo Bio Partners has
started construction of two new manufacturing suites at its
facility in Amsterdam, the Netherlands, in a move that builds on
the firm's ability to make microbial...
According to a recent report, the emerging market for protein
microarrays will experience strong growth buoyed on by the
emergence of the technology's ability to detect protein expression
more quickly and easily than traditional...
S R Pharma have released its interim results for the first half of
2005, which show the continued consolidation of Research and
Development costs as resources were diverted to acquire contract
development services provider, Atugen.
Celtic Pharma has announced the acquisition of a stake in IDEA - a
biopharma company, which is developing targeted therapeutics based
on novel, Transfersome carriers that can increase drug potency and
diminish harmful side effects.
DecisionNews Media is seeking a further reporter for its
pharmaceuticals industry news services. Applicants must be
exceptionally bright, ambitious and talented, with experience in
news writing on the pharmaceuticals industry.
New discoveries and innovative technologies will create growth
opportunities in the in-vitro diagnostics (IVD) market with
molecular diagnostic assays set to feature strongly in the
development of personalised medicine and theranostics.
PANalytical has added a new focusing mirror to its range of PreFIX
optics that for the first time, can analyse macromolecules using a
standard, laboratory-based XRD system, rather than on a synchrotron
beam line or a single crystal...
German packaging company Gerresheimer has announced plans to take
over the pharmaceutical business of troubled Glass Group Inc (GGI)
of the US, after a Delaware bankruptcy court approved the
Galapagos has announced that its acquisition of BioFocus' would
accelerate its transition to a fully integrated drug development
biopharmaceutical company after the two companies reached agreement
on the terms of a recommended...
Celsis International has signed a collaboration with BioVentures to
develop a microarray-based microbiological testing system to detect
contamination in pharmaceutical, biotechnology and other process